Neurology Devices

Request for TOC Request for Sample
BUY NOW

U.S. Intra Cranial Pressure (ICP) Monitoring Devices Market – Industry Trends and Forecast to 2029

Neurology Devices | Upcoming Report | May 2022 | Country Level | 150 Pages | No of Tables: 30 | No of Figures: 50

COVID-19 Impact on the Lubricants in Chemical and Materials Industry COVID-19 Impact on Retinoic Acid in Healthcare Industry COVID-19 Impact on Anti-Corrosion Lubricant in Chemical and Materials Industry COVID-19 Impact on Zoledronic Acid in Chemicals and Materials Industry

Report Description

U.S. Intra Cranial Pressure (ICP) monitoring devices Market, By Route of Intervention (Intraventricular, Epidural Sensor), Technique (Invasive, Non-Invasive), Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Meningitis), Device (Intraventricular Catheter, Subarachnoid Screw, Non Invasive Intra Cranial Pressure Monitors, Epidural Sensors), End-User (Hospitals and Clinics, Trauma Centers) – Industry Trends and Forecast to 2029

Market Analysis and Size

Intracranial pressure monitoring is a useful tool for diagnosing and treating neurological conditions such as intracerebral and subarachnoid haemorrhage, hydrocephalus, ischemic stroke, traumatic brain injury (TBI), and meningitis/encephalitis. Intracranial pressure monitoring has progressed from an intrusive technique to a non-invasive technology over the previous few decades, with both benefits and drawbacks. Any increase in cranial volume could exacerbate intracranial hypertension.

Data Bridge Market Research analyses that the intra cranial pressure (ICP) monitoring devices market which was USD 219.1 million in 2021, would rocket up to USD 354.52 million by 2029, and is expected to undergo a CAGR of 6.2% during the forecast period 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Intracranial pressure monitoring devices are devices that measure pressure in the skull as a result of accidents or injuries. The major factor driving market growth is the rising incidence of neurovascular disorders such as arteriovenous malformations (AVMs) and brain aneurysms, as well as the rising cases of trauma and brain injuries, while increasing demand for minimally invasive treatments and rising government initiatives to improve healthcare infrastructure will boost market growth.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Route of Intervention (Intraventricular, Epidural Sensor), Technique (Invasive, Non-Invasive), Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Meningitis), Device (Intraventricular Catheter, Subarachnoid Screw, Non Invasive Intra Cranial Pressure Monitors, Epidural Sensors), End-User (Hospitals and Clinics, Trauma Centers)

Market Players Covered

Medtronic (Ireland), Johnson & Johnson Private Limited (U.S), RAUMEDIC AG (Germany), Integra LifeSciences (U.S), Natus Medical Incorporated (U.S), Terumo Corporation (Japan), Sophysa (France), Spiegelberg GmbH & Co. KG (U.S), Compumedics Limited (Australia), Shurtleff, Inc. (US), HeadSense Medical (U.S), NeuroDx Development (U.S), Third Eye Diagnostics (U.S), Vivonics Inc. (U.S), Covidien plc (Ireland), Linet (Czechia)

Market Opportunities

  • Governments of several countries are spending on improving the healthcare infrastructure
  • Rising incidence of neurological conditions

Intra Cranial Pressure (ICP) Monitoring Devices Market Dynamics

Drivers

  • Owing to the increasing cases of coronavirus disease (COVID-19)

The demand for high-quality care for patients in life-threatening situations is growing all over the world. As a result, the growth of the intra cranial pressure (ICP) monitor market is bolstered, as these devices are utilised to monitor patients in intensive care. Furthermore, the rising prevalence of autoimmune, cardiovascular, and sleep diseases has fueled demand for ICT monitors that can deliver timely and effective therapy. Furthermore, some nations' governments are investing in enhancing healthcare infrastructure and critical care centres, which is likely to enhance monitor sales. In addition, firms are working on developing an intra cranial pressure (ICP) monitoring equipment for home usage. Such advancements are projected to positively impact market growth during the next several years.

  • High need for innovative Intra Cranial Pressure (ICP) sensors

In 2021, the intra cranial pressure (ICP) monitoring product category, driven by intra cranial pressure (ICP) monitoring sensors, accounted for more than 85% of the overall market by value. The increasing demand for measuring increased intracranial pressure owing to any accident or condition is the cause for this large market share. Intra cranial pressure (ICP) monitoring devices are diagnostic devices that use a small pressure-sensitive probe placed into the skull to help doctors assess the pressure of cerebrospinal fluid and whether it is high or low.

  • High incidence of Traumatic Brain Injury (TBI)

According to estimates, traumatic brain injury has a market share of more than 37% in 2021. This is because of high number of people who have suffered traumatic brain injuries as a result of car accidents. Intracranial pressure rises as a result of traumatic brain damage, which must be monitored and treated via intracranial pressure monitoring equipment. This has resulted in a huge demand for intracranial pressure monitoring devices all around the world.

Opportunities

  • Rising incidence of neurological conditions

Manufacturers of intra cranial pressure (ICP) monitoring systems around the world will have plenty of lucrative prospects in the next years. A few important market players have consolidated the industry. These players will face competition from emerging economies. Manufacturers of intra cranial pressure (ICP) monitoring devices have a huge chance to expand their businesses in countries like China, Japan, and India, due to the vast number of elderly people who are at the highest risk of neurological problems. As a result, intra cranial pressure (ICP) monitoring equipment are required for routine monitoring of any neurological illness.

Restraints/Challenges

  • High Intra Cranial Pressure (ICP) Monitoring product cost

Intra cranial pressure (ICP) monitoring instruments and methods are relatively expensive, making them unaffordable for a large number of individuals, particularly in developing countries like India. The price of Digitimer's NL108T4 Re-Useable Physiological Pressure Transducer, for example, is US$ 801, which is out of reach for those from lower socioeconomic backgrounds all around the world. As a result, the product's high cost has an impact on sales and revenue, as well as limiting market growth to some extent. Intra cranial pressure (ICP) monitoring is a complicated operation that necessitates the use of qualified and skilled medical personnel. Because it's an intrusive technique that necessitates surgery, the procedure's sensitivity is greatly increased. Any error made during the surgery could result in a significant medical problem. Mistakes while placing the probe in the brain can even lead to death. There is lack of trained medical professionals, which negatively disturbs market growth.

This intra cranial pressure (ICP) monitoring devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the intra cranial pressure (ICP) monitoring devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Intra Cranial Pressure (ICP) Monitoring Devices Market

The COVID-19 epidemic and subsequent lockdowns wreaked havoc on most businesses throughout the world. Depending on the segment they were working with, the pharmaceutical, biotechnology, and medical device businesses saw both positive and bad effects from the epidemic. The pandemic had a negative influence on the U.S. market for intracranial pressure monitoring. It shifted the world's attention on the virology industry, with negative consequences for most other industries. Due to fewer traffic accidents and traumatic injury cases, clinic footfall has decreased, resulting in less intra cranial pressure (ICP) monitoring need and, as a result, less demand for intra cranial pressure (ICP) monitoring devices.

 Recent Development

 DePuy Synthes partnered with Expanding Innovations Inc. to distribute the X-Pac Expandable Lumbar Cage System in the United States in February 2021. It aided the company's expansion into the country.

 In 2021, the traumatic brain injury category dominated the intracranial pressure monitoring device market, accounting for roughly 31.6 percent of total revenue.

U.S. Intra Cranial Pressure (ICP) Monitoring Devices Market Scope

The intra cranial pressure (ICP) monitoring devices market is segmented on the basis of product, route of intervention, indication and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

Accessories

  • Intraventricular Catheters
  • Subdural Catheters
  • Parenchymal Catheters
  • Epidural Sensors
  • Sub Arachnoid Screws

Route of Intervention

  • Intraventricular ICP Monitoring
  • Subdural ICP Monitoring
  • Epidural ICP Monitoring
  • Parenchymal ICP Monitoring
  • Subarachnoid ICP Monitoring

Indication

  • Traumatic Brain Injury
  • Intracerebral Haemorrhage
  • Subarachnoid haemorrhage
  • Hydrocephalus
  • Malignant Cerebral Infarction (MCI)
  • Cerebral Edema
  • CNS infections
  • Others

End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Trauma Centers
  • Neurosurgery Centers

Healthcare Infrastructure growth Installed base and New Technology Penetration

The intra cranial pressure (ICP) monitoring devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for intra cranial pressure (ICP) monitoring devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the intra cranial pressure (ICP) monitoring devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Intra Cranial Pressure (ICP) Monitoring Devices Market Share Analysis

The intra cranial pressure (ICP) monitoring devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, U.S. presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to intra cranial pressure (ICP) monitoring devices market.

Some of the major players operating in the intra cranial pressure (ICP) monitoring devices market are:

  • Medtronic (Ireland)
  • Johnson & Johnson Private Limited (U.S)
  • RAUMEDIC AG (Germany)
  • Integra LifeSciences (U.S)
  • Natus Medical Incorporated (U.S)
  • Terumo Corporation (Japan)
  • Sophysa (France) 
  • Spiegelberg GmbH & Co. KG (U.S)
  • Compumedics Limited (Australia)
  • Shurtleff, Inc. (US),
  • HeadSense Medical (U.S)
  • NeuroDx Development (U.S)
  • Third Eye Diagnostics (U.S)
  • Vivonics Inc. (U.S)
  • Covidien plc (Ireland)
  • Linet (Czechia)


SKU-

Table of Content

Please fill in the below form for detailed Table of Content

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Table

Please fill in the below form for detailed List of Table

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Figure

Please fill in the below form for detailed List of Figure

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

View Infographics

Please fill in the below form for detailed Infographics

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country
CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19